Austria Denmark Germany Netherlands UKAn in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes

July 19, 2022by pcdata

Dates: 01/02/2018
31/07/2023

Topic: Tool
AI/Big Data

Project type: Preclinic

Project target: Neurology
Cardiovascular disease

Financing:

H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being
H2020-EU.3.1.5. – Methods and data

Participating agents:

UNIVERSITEIT MAASTRICHT

Keywords: drug repurposing; biomarker; cerebro-cardiovascular; in-silico; clinical trial; efficacy

Countries: Denmark; UK; Germany; Netherlands; Austria

Project page: Access page